Executive Appointment

United States – – October 05, 2026 -- Medical device contract manufacturer KMM Group has named Amy Goff and Erica Blake to senior leadership roles, deepening its operational and financial bench as the company expands production capacity following a platform investment from RS2 Healthcare Partners.

KMM strengthens leadership after July 2026 CEO appointment and RS2 investment

The hires follow J. Mark King's July 2026 appointment as president and CEO and the completion of RS2 Healthcare Partners' platform investment in KMM. King said the additions align with KMM's expansion plans, citing Goff's operations and supply chain background and Blake's finance experience in complex manufacturing transitions.

Seattle – October 03, 2026 -- ORSNN, an electronic trading platform for institutional whole loan markets, has named Aaron Khoo as Chief Product Officer and Werner Koepf as Chief Technology Officer, while adding Ken Plank as Senior Advisor, Credit Unions, as the company nears completion of a new capital raise.

The platform has supported $3 billion in loan offering volume to date and completed its SOC 2 Type I examination in the second quarter of 2026. The capital raise will fund continued product development, engineering execution and expansion into new markets, the company said.

Irvine, Calif. – October 02, 2026 -- MobileX has appointed Raju Datla as Chief Financial Officer, bringing more than 25 years of telecom, infrastructure and capital markets experience to the wireless carrier as it scales distribution and its AI-driven service platform.

Datla joins from RedCloud Holdings after leading its global finance and capital markets strategy

Datla most recently served as CFO of Nasdaq-listed RedCloud Holdings (NASDAQ: RCT), overseeing finance, capital markets and the financial execution of the company's global expansion. He previously held the Chief Strategy Officer role at Tillman Fiber and was CFO and co-founder of NxtGen Datacenter & Cloud Technologies.

Toronto – – October 01, 2026 -- Info-Tech Research Group has appointed Kim Chanderbir as Senior Managing Partner II for Financial & Professional Services, adding more than 30 years of executive leadership experience to its advisory bench as demand grows for outcomes-driven consulting in regulated sectors.

Chanderbir has managed portfolios exceeding $550 million across global markets

Her career spans financial services, insurance, fintech, SaaS, technology, government, and healthcare, where she led enterprise modernization, managed services, and client success mandates. She has overseen teams of more than 1,000 professionals across North America, EMEA, APAC, LATAM, and Japan.

Hollywood, Fla. – October 01, 2026 -- Memorial Healthcare System has appointed Madison Workman, FACHE, as chief executive officer of Memorial Hospital Pembroke, a 301-bed facility in Pembroke Pines, placing him in charge of operations and growth strategy at the hospital.

Workman Previously Oversaw $100 Million in Capital Projects at Broward Health North

Workman joins from Broward Health North, a 409-bed Level II trauma hospital, where he served as chief operating officer managing roughly 800 employees across clinical and support services. He expanded his role to lead the systemwide Safety and Security program and the COO Council, while helping direct more than $100 million in construction and capital investment focused on patient throughput and hospital expansion.

Southlake, Texas – October 01, 2026 -- Sabre Corporation (NASDAQ: SABR) has elected Rochelle Boas as Executive Vice President – Chief Legal and Administrative Officer, effective immediately, expanding her mandate beyond the Legal organization to oversee the company's People Team.

Boas gains oversight of HR as Chief People Officer Dave Medrano now reports to her

Under the restructuring, Dave Medrano, Sabre's Chief People Officer, will report directly to Boas, consolidating the travel technology company's legal and human resources functions under a single executive.

Boas joined Sabre in 2024 as Chief Legal Officer and sits on the executive leadership team

Boas has served as Sabre's Executive Vice President – Chief Legal Officer since 2024 and will continue to lead the Legal organization alongside her new administrative responsibilities.

Dublin – October 01, 2026 -- Neuromod Devices has appointed Joe Ghiz as Chief Commercial Officer and Shannon Basham as VP of Channel Development, moves aimed at accelerating global commercial expansion of its tinnitus treatment device, Lenire.

Philadelphia – October 01, 2026 -- Children's Hospital of Philadelphia (CHOP) has officially installed Joseph Mitchell, MD, as President and Chief Executive Officer, succeeding Madeline Bell after her nearly four-decade tenure and 11 years as CEO.

Mitchell completes an 18-month transition after joining CHOP as President in April 2025

Mitchell spent the past year and a half working alongside CHOP leadership, clinicians, researchers and community partners ahead of taking full control of the nation's first children's hospital, an institution founded more than 170 years ago.

London – October 01, 2026 -- Teciem, a global provider of front-to-back treasury and capital markets software, has appointed Stefano Maestri as Chief Technology Officer and Strath Lanyon as Chief Customer Officer, both based in London and reporting directly to CEO Wissam Khoury.

Teciem expands leadership six months after company launch

The appointments come just over six months after Teciem's launch, as the firm builds out its executive team to support cloud-native deployment and AI-enabled product development for financial institutions managing increasingly complex transformation programs.

Singapore – October 01, 2026 -- Emerald Clinical Trials has appointed Michael Stibilj as Chief Executive Officer, effective October 01, 2026, tasking the 30-year CRO veteran with leading the next phase of growth for a platform that now spans more than 1,000 professionals across 40-plus countries and 70-plus locations.

Stibilj joins from six years as Chief Operating Officer at Novotech

Before Novotech, Stibilj served three years as CEO of PPC Group and spent 22 years at IQVIA in regional and global leadership roles, with operational experience across China, Singapore and Australia.

Appointment follows the acquisition of Hongyi Clinical Development Services

The deal combined Emerald with Hongyi to create a clinical development platform supporting sponsors from first-in-human trials through post-marketing across China, Asia-Pacific, Europe and the Americas.